Historical Stock Price
OCRX historical stock prices picture
OCRX (OCRX) has the following price history information. Looking back at OCRX historical stock prices for the last five trading days, on December 05, 2017, OCRX opened at $1.75, traded as high as $1.77 and as low as $1.74, and closed at $1.77. Trading volume was a total of 181.40K shares. On December 06, 2017, OCRX opened at $1.75, traded as high as $1.78 and as low as $1.75, and closed at $1.76. Trading volume was a total of 317.20K shares. On December 07, 2017, OCRX opened at $1.76, traded as high as $1.78 and as low as $1.75, and closed at $1.77. Trading volume was a total of 205.00K shares. On December 08, 2017, OCRX opened at $1.76, traded as high as $1.85 and as low as $1.76, and closed at $1.79. Trading volume was a total of 969.40K shares. On December 11, 2017, OCRX opened at $1.79, traded as high as $1.79 and as low as $1.79, and closed at $1.79. Trading volume was a total of 0 shares.

OCRX Historical Stock Prices By Date:

OCRX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into OCRX shares, starting with a $10,000 purchase of OCRX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 12/11/2017
Start price/share: $8.69
End price/share: $1.79
Dividends collected/share: $0.00
Total return: -79.40%
Average Annual Total Return: -35.20%
Starting investment: $10,000.00
Ending investment: $2,060.28
Years: 3.64
Date Open High Low Close Volume
12/05/2017 $1.75 $1.77 $1.74 $1.77 181.40K
12/06/2017 $1.75 $1.78 $1.75 $1.76 317.20K
12/07/2017 $1.76 $1.78 $1.75 $1.77 205.00K
12/08/2017 $1.76 $1.85 $1.76 $1.79 969.40K
12/11/2017 $1.79 $1.79 $1.79 $1.79 0
Ocera Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of a clinical product candidate, OCR-002 (ornithine phenylacetate), in both intravenous and oral formulations, for the treatment of hepatic encephalopathy (HE). OCR-002 is a molecule, ornithine phenylacetate, which functions as an ammonia scavenger. Co. is conducting a clinical trial to evaluate the safety, tolerability and efficacy of intravenously-administered OCR-002 in resolving neurocognitive symptoms of acute HE. Co. is also developing an oral form of OCR-002 which provides care for HE patients post discharge to prevent subsequent episodes of acute HE.
Date Close
12/05/2017$1.77
12/06/2017$1.76
12/07/2017$1.77
12/08/2017$1.79
12/11/2017$1.79
OCRX is categorized under the Healthcare sector; below are some other companies in the same sector:

OCUL Historical Stock Prices
OCX Historical Stock Prices
ODT Historical Stock Prices
OFIX Historical Stock Prices
OGEN Historical Stock Prices
OGXI Historical Stock Prices
OHRP Historical Stock Prices
OMED Historical Stock Prices
OMER Historical Stock Prices
OMI Historical Stock Prices

Email EnvelopeFree OCRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


OCRX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.